Keywords: roche, outperformer, make, acquisition, swiss, drugs, major

Roche An Outperformer; Will Make Acquisition?

Article | 19 October 1998

Print This

Swiss drugs major Hoffmann-La Roche will be a stock market outperformer,according to analysts at Lehman Brothers. However, as a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in